Health
Dengue fever outbreaks are on the rise in Brazil
Cases of a mosquito-borne disease have soared in Brazil during the hot rainy season, prompting authorities to take emergency measures. The São Paulo state health
Ozempic reduces the severity of liver disease in people with HIV
A weekly injection of semaglutide is safe and reduces liver fat by 31% in people with HIV and some type of liver disease, data from
US to accelerate some payments to hospitals after UnitedHealth hack
The US government said on Tuesday it would accelerate Medicare and Medicaid payments to some hospitals affected by the hack of insurance company UnitedHealth’s technology
US FDA has authorised the first over-the-counter continuous glucose monitor
The health regulator said the US Food and Drug Administration has authorised the Dexcom Device, making it the first continuous glucose monitor available without a
The US FDA has approved the eye drug Eyenovia
The US Food and Drug Administration has approved Eyenovia eye drops to reduce inflammation and pain in patients who have undergone eye surgery, Taiwan-based Formosa
French lawmakers have made abortion a constitutional right
France on Monday enshrined the right to abortion in its constitution. MPs and senators overwhelmingly backed the move, by 780 votes to 72, in an
GSK’s new HIV drug formulation may support longer dosing intervals
GSK said the new HIV prevention and treatment formulation could potentially be administered at least every four months, an improvement over the previous requirement of
CVS and Walgreens will start selling abortion pills this month
CVS and Walgreens, the two largest US pharmacy chains, will begin selling mifepristone abortion pills in shops in several states this month, drawing praise from
Bayer to purchase a heart drug for up to $310 million
Bayer said Monday it has acquired exclusive marketing rights in Europe for a new drug under regulatory review to treat a rare, potentially fatal heart
FDA approves J&J combination therapy to treat a type of lung cancer
A US health regulator has approved Johnson & Johnson’s Uterapia in combination with other chemotherapy drugs for the first-line treatment of lung cancer. The FDA